AI-generated summary
The authors report a randomized trial of 131 patients with varicose veins treated with laser ablation or radiofrequency ablation, with 110 attending 6-month follow-up. Both treatments were associated with comparable improvements in quality of life and clinical scores, and the authors found EVLA more likely to be cost-effective, though cost and quality-of-life differences were small and not statistically significant.
- Participants
- 131
- Who or what was studied
- Patients with symptomatic primary varicose veins
- Limits stated in the abstract
- Cost and quality-of-life differences between groups were small and not statistically significant, and 21 randomized patients did not attend 6-month follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on cambridge.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.